Dr Chirag Oza is a Consultant Gastroenterologist who specialises in hepatology
Hepatology, Deranged LFT's, NASH (Non-alcoholic Steatohepatitis), NAFLD (Non-alcoholic Fatty Liver Disease), Alcohol-related liver disease, Cirrhosis, Auto-immune liver disease, Cholangiopathies, Therapeutic, interventional, and diagnostic endoscopy, Variceal banding, Upper and lower GI stenting, Biliary duct stone extraction, Investigations for IBS (Irritable Bowel Syndrome), Investigations for IBD (Inflammatory Bowel Disease), Colitis, Crohn's disease, Coeliac disease, Stenting of benign/malignant strictures, Biliary cancer diagnosis, Dyspepsia, Chronic pancreatitis, Pancreatico-biliary disorders, Reflux, Dysphagia, Upper quadrant pain (pain under ribs), Endoscopic ultrasound (EUS), Diagnostic colonoscopy, Viral hepatitis NAFLD NASH auto-immune liver disorders, Hepato-pancreato-biliary (at MEHT), Diagnostic & therapeutic biliary duct stone extraction gastrointestinal upper GI endoscopy & colonoscopy, Upper & lower stenting of malignant strictures (at MEHT)
General Medical Council - GMC No. 6049863
British Society of Gastroenterology (BSG)
British Association for the Study of the Liver (BASL)
European Association for the Study of the Liver (EASL)
Fellowship of the Royal College of Physicians (FRCP)
Dr Chriag Oza is an NHS Consultant Hepatologist, specialising in investigating and treating patients with primary liver conditions, like fatty liver disease, auto immune liver diseases and alcohol-related liver disease. Additionally, Dr Oza will diagnose and treat patients with viral hepatitis, and look after patients with decompensated liver cirrhosis, and patients who have had liver transplants. Dr Oza has close links with the Liver Transplant Unit at Addenbrooke's Hospital.
Dr Oza also investigates patients with possible pancreatic or hepatobiliary cancers, and can provide diagnostic and therapeutic Endoscopic Ultrasound, and therapeutic ERCP (both in the NHS sector only currently), as well as therapeutic Upper GI endoscopy (in the Private sector)
Broomfield Hospital (MEHT) - Consultant and Clinical Lead for Gastroenterology and Endoscopy / Consultant Hepatologist. Addition
6049863
Hepatology, Deranged LFT's, NASH (Non-alcoholic Steatohepatitis), NAFLD (Non-alcoholic Fatty Liver Disease), Alcohol-related liver disease, Cirrhosis, Auto-immune liver disease, Cholangiopathies, Therapeutic, interventional, and diagnostic endoscopy, Variceal banding, Upper and lower GI stenting, Biliary duct stone extraction, Investigations for IBS (Irritable Bowel Syndrome), Investigations for IBD (Inflammatory Bowel Disease), Colitis, Crohn's disease, Coeliac disease, Stenting of benign/malignant strictures, Biliary cancer diagnosis, Dyspepsia, Chronic pancreatitis, Pancreatico-biliary disorders, Reflux, Dysphagia, Upper quadrant pain (pain under ribs), Endoscopic ultrasound (EUS), Diagnostic colonoscopy, Viral hepatitis NAFLD NASH auto-immune liver disorders, Hepato-pancreato-biliary (at MEHT), Diagnostic & therapeutic biliary duct stone extraction gastrointestinal upper GI endoscopy & colonoscopy, Upper & lower stenting of malignant strictures (at MEHT)
General Medical Council - GMC No. 6049863
British Society of Gastroenterology (BSG)
British Association for the Study of the Liver (BASL)
European Association for the Study of the Liver (EASL)
Fellowship of the Royal College of Physicians (FRCP)
Dr Chriag Oza is an NHS Consultant Hepatologist, specialising in investigating and treating patients with primary liver conditions, like fatty liver disease, auto immune liver diseases and alcohol-related liver disease. Additionally, Dr Oza will diagnose and treat patients with viral hepatitis, and look after patients with decompensated liver cirrhosis, and patients who have had liver transplants. Dr Oza has close links with the Liver Transplant Unit at Addenbrooke's Hospital.
Dr Oza also investigates patients with possible pancreatic or hepatobiliary cancers, and can provide diagnostic and therapeutic Endoscopic Ultrasound, and therapeutic ERCP (both in the NHS sector only currently), as well as therapeutic Upper GI endoscopy (in the Private sector)